Herpetic Neuralgia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

New Shingles Vaccine Found to Be More Effective | Everyday Health - Everyday Health, Inc. (blog)



Everyday Health, Inc. (blog)
 
New Shingles Vaccine Found to Be More Effective | Everyday Health 
Everyday Health, Inc. (blog)
A newly available shingles vaccine is more effective at preventing the painful condition, a development that may convince more people to get vaccinated.
New shingles vaccination keeps the pox from striking back in older ... Calgary Herald

all 2 news articles » 


Should Gabapentin Be a Controlled Substance? - Pain News Network



Pain News Network
 
Should Gabapentin Be a Controlled Substance? 
Pain News Network
The U.S. Drug Enforcement Administration should consider scheduling gabapentin (Neurontin) as a controlled substance, according to researchers who studied the recreational use of the drug in Kentucky. Gabapentin is a nerve medication approved by the ...

 


Global Postherpetic Neuralgia API Manufacturers, Marketed and Phase III Drugs Landscape Report 2018 ... - Business Wire (press release)



Global Postherpetic Neuralgia API Manufacturers, Marketed and Phase III Drugs Landscape Report 2018 ... 
Business Wire (press release)
Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018' report provides comprehensive insights about marketed and Phase III products for Postherpetic Neuralgia . The report includes information of marketed ...

and more » 


What Rheumatologists Need to Know in the Era of Herpes Zoster ... - Healio



What Rheumatologists Need to Know in the Era of Herpes Zoster ... 
Healio
Healio Rheumatology | Herpes zoster has become a topic of increasing interest and importance to our profession over the past number of years for several reasons, the most pressing of which is that our patients are 1.5 to 2 times more likely to develop ...

and more » 


Shot may help shield against shingles - Science Daily



Shot may help shield against shingles 
Science Daily
According to Dr. Rosamilia, early treatment not only can reduce the pain and severity of the disease, but also can help prevent potential side effects like eye problems, infection, and a condition called post-herpetic neuralgia, which causes pain ...

 


Recognizing the pain of shingles, treating the virus - taosnews



taosnews
 
Recognizing the pain of shingles, treating the virus 
taosnews
Most people fully recover from shingles. However, a condition in which the nerve continues to be damaged after the rash has healed can occur. It is called post-herpetic neuralgia (PHN). Only 10 percent of shingles cases will lead to PHN. Pain ...

 


Reaffirmed: Acorda Therapeutics (NASDAQ:ACOR) Hold Rating ... - BZ Weekly



BZ Weekly
 


Computed tomography-guided percutaneous ozone injection of the Gasserian ganglion for the treatment of trigeminal ... - Dove Medical Press



Dove Medical Press
 
Computed tomography-guided percutaneous ozone injection of the Gasserian ganglion for the treatment of trigeminal ... 
Dove Medical Press
Patients and methods: A total of 29 patients with a clinical diagnosis of refractory trigeminal neuralgia were enrolled. All patients were treated with a percutaneous ozone injection and one patient was excluded. There were 21 patients with classical ...

 


FDA Investigating Misuse, Abuse of Gabapentinoids - MedPage Today



MedPage Today
 
FDA Investigating Misuse, Abuse of Gabapentinoids 
MedPage Today
WASHINGTON -- The FDA is looking at whether gabapentinoids are an addiction threat, FDA Commissioner Scott Gottlieb, MD, said Thursday. Gabapentinoids such as pregabalin (Lyrica) as well as the original agent gabapentin (Neurontin) are approved to ...
Gottlieb: FDA Looking Beyond Opioids in Overdose Epidemic Regulatory Focus

all 11 news articles » 


Why Sorrento Therapeutics Jumped Higher Today - Motley Fool



Why Sorrento Therapeutics Jumped Higher Today 
Motley Fool
Sorrento is expecting the Food and Drug Administration to rule on its marketing application for ZTlido, a lidocaine patch to treat post-herpetic neuralgia -- the pain caused by shingles -- on or about Feb. 28. The so-called Prescription Drug User Fee ...

and more »